I believe that more must be done to improve both transparency and the oversight of drug products after they reach the market to ensure safety.
Tammy Baldwin: “I believe that more must be done to improve both transparency and the oversight of drug products after they reach the…”
On the recordNovember 16, 2015
Source
congress.govEditor's note · Context
Calls for enhanced transparency and oversight of drug safety post-market.
Share
More from Tammy Baldwin
Oct 16, 2026
But when aging infrastructure causes delays and disruptions, it hurts our businesses, costs them time and money, and makes it harder for them to compete.
Oct 13, 2026
By requiring each Dairy Business Innovation Center to provide a match that Congress never intended and centers do not have the resources to meet, USDA is threatening the program’s survival and the success of the farmers and producers that…
Oct 14, 2026
Wisconsin truck drivers work hard every day to deliver the goods we rely on, support our farmers and manufacturers, and keep our Made in Wisconsin economy moving forward.





